BR9913025A - Uso de um composto - Google Patents

Uso de um composto

Info

Publication number
BR9913025A
BR9913025A BR9913025-4A BR9913025A BR9913025A BR 9913025 A BR9913025 A BR 9913025A BR 9913025 A BR9913025 A BR 9913025A BR 9913025 A BR9913025 A BR 9913025A
Authority
BR
Brazil
Prior art keywords
compound
taxoid
concerns
brain
precisely
Prior art date
Application number
BR9913025-4A
Other languages
English (en)
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Priority claimed from PCT/EP1999/006291 external-priority patent/WO2000009120A1/en
Publication of BR9913025A publication Critical patent/BR9913025A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

"USO DE UM COMPOSTO". A presente invenção diz respeito a um novo uso de derivados de taxóide. Diz respeito mais precisamente a um método para o tratamento de proliferação celular anormal no cérebro de mamíferos incluindo o homem pela administração de um derivado de taxóide.
BR9913025-4A 1998-08-17 1999-08-13 Uso de um composto BR9913025A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98115401A EP0982027A1 (en) 1998-08-17 1998-08-17 Taxoid derivatives for treating abnormal cell proliferation of the brain
PCT/EP1999/006291 WO2000009120A1 (en) 1998-08-17 1999-08-13 New use of taxoid derivatives

Publications (1)

Publication Number Publication Date
BR9913025A true BR9913025A (pt) 2001-05-08

Family

ID=8232465

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913025-4A BR9913025A (pt) 1998-08-17 1999-08-13 Uso de um composto

Country Status (7)

Country Link
EP (1) EP0982027A1 (pt)
CN (1) CN1200707C (pt)
BR (1) BR9913025A (pt)
EA (1) EA005135B1 (pt)
PL (1) PL346113A1 (pt)
UA (1) UA70332C2 (pt)
ZA (1) ZA200101292B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
CN1200707C (zh) 2005-05-11
EP0982027A1 (en) 2000-03-01
EA200100248A1 (ru) 2001-08-27
CN1367691A (zh) 2002-09-04
PL346113A1 (en) 2002-01-28
ZA200101292B (en) 2001-08-21
UA70332C2 (en) 2004-10-15
EA005135B1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
PL343156A1 (en) Method for stabilizing pharmaceutical compositions by special use of an antioxidant
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ATE119522T1 (de) Substituierte cyclohexanole mit zentraler nervensystemwirkung.
YU401A (sh) Sredstva sa antidepresivnim dejstvom
ES2106700T3 (es) Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas.
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
GR3019490T3 (en) Substituted piperazines as central nervous system agents
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
IL99975A0 (en) 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
YU7901A (sh) Nova primena derivata taksoida
FI964045A0 (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
BR9913025A (pt) Uso de um composto
MY129575A (en) Methods, kits and compositions for using pyrrole derivatives againts anxiety
ES2173586T3 (es) Derivados de ciclohexandiol.
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
BR0010540A (pt) Processo para a preparação de uma anilina substituìda, e, para a preparação de uma fenilidrazina substituìda
MY124089A (en) Use of cetirizine for preventing the onset of asthma
BR9714382A (pt) 17alfa-diidroequilina para uso como um antioxidante médico
PT930879E (pt) Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
UA84544C2 (ru) Замещенные фенилсульфонамидные ингибиторы продукции бета-амилоида

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO ESTABELECIDO PELOS ARTIGOS 8O E 11 DA LPI ( LEI 9279/96 )

B12B Appeal: appeal against refusal